Novartis AG
XHAM:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XHAM:NOT
|
CH |
|
J
|
JAFCO Group Co Ltd
F:JAF
|
JP |
|
R
|
Range Resources Corp
DUS:RAX
|
US |
|
F
|
FL Entertainment NV
F:H98
|
FR |
|
C
|
California Water Service Group
F:WT5
|
US |
|
D
|
DR Horton Inc
DUS:HO2
|
US |
|
M
|
Marathon Digital Holdings Inc
F:M44
|
US |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
XMUN:G7A
|
MX |
|
Advanced Drainage Systems Inc
F:6DA
|
US |
|
X
|
Xylem Inc
F:XY6
|
US |
|
Relief Therapeutics Holding SA
OTC:RLFTF
|
CH |
|
Danone SA
PAR:BN
|
FR |
|
E
|
Envista Holdings Corp
F:0HV
|
US |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
Smith & Nephew PLC
F:NPW1
|
UK |
|
G
|
Globaltrans Investment PLC
F:G23A
|
CY |
|
Evertec Inc
F:2EV
|
PR |
|
V
|
Valtecne SpA
MIL:VLT
|
IT |
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
P
|
PostNL NV
DUS:TNTC
|
NL |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
|
A
|
Advantest Corp
SWB:VAN
|
JP |
|
DIRTT Environmental Solutions Ltd
OTC:DRTTF
|
CA |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 136.41 EUR with a low forecast of 104.48 EUR and a high forecast of 160.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
136.41
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 136.41 EUR with a low forecast of 104.48 EUR and a high forecast of 160.06 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
